BioVersys is a privately held Swiss biopharmaceutical company.
Bioversys AG is a privately held Swiss biopharmaceutical company located in Basel that focuses on research and development of new drugs and compounds, which switch-off drug resistance within bacterial pathogens and restore the efficacy of approved antibiotics. Spun out of the ETH-Zurich in 2008, we have profound technological expertise that is based on solid IP.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 14, 2021 | Debt Financing | €20M | 1 | European Investment Bank | — | Detail |
Mar 31, 2011 | Seed | Fr2.50M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
European Investment Bank | Yes | Debt Financing |
BioValley Business Angels Club (BioBAC) | — | Seed |